Results 231 to 240 of about 27,368 (256)
Familial polyposis syndrome and achalasia in a young adult. [PDF]
JPGN RepLorusso Vivas GA +2 more
europepmc +1 more source
When Manometry and Functional Lumen Imaging Probe Disagree: The Current Limitations of the Chicago Classification Version 4.0 and Probable Extended Indications of Functional Lumen Imaging Probe. [PDF]
J Neurogastroenterol MotilJung KW, Pandolfino JE.
europepmc +1 more source
Factors associated with the development of bacterial pneumonia and the preventive potential of peroral endoscopic myotomy in patients with esophageal motility disorders: a case-control study. [PDF]
J GastroenterolHori H +13 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Treatment Options in Gastroenterology, 2001
The optimal treatment of achalasia includes several options and presents a challenge for most gastroenterologists. There are numerous patient variables that must be assessed including age, degree of symptoms, duration of disease, desires of each patient, and related comorbidities.
Roy K. H. Wong, Peter M. Dunaway
openaire +3 more sources
The optimal treatment of achalasia includes several options and presents a challenge for most gastroenterologists. There are numerous patient variables that must be assessed including age, degree of symptoms, duration of disease, desires of each patient, and related comorbidities.
Roy K. H. Wong, Peter M. Dunaway
openaire +3 more sources
Gastroenterology Clinics of North America, 1989
Achalasia is a chronic illness that can be treated effectively in 65 to 90 per cent of patients with either pneumatic dilatation or Heller esophagomyotomy. Prior to institution of therapy, clinicians must rule out secondary achalasia, especially malignancy-associated achalasia, with upper endoscopy, and if the clinical history is worrisome for ...
J C, Reynolds, H P, Parkman
openaire +2 more sources
Achalasia is a chronic illness that can be treated effectively in 65 to 90 per cent of patients with either pneumatic dilatation or Heller esophagomyotomy. Prior to institution of therapy, clinicians must rule out secondary achalasia, especially malignancy-associated achalasia, with upper endoscopy, and if the clinical history is worrisome for ...
J C, Reynolds, H P, Parkman
openaire +2 more sources
Surgical Clinics of North America, 2011
This article reviews the diagnosis and treatment of achalasia, a rare esophageal motility disorder characterized by absent peristalsis and failure of the lower esophageal sphincter (LES) to relax. Various treatment options including management with sublingual nitrates or calcium channel blockers, injection of the LES with botulism toxin, pneumatic ...
William C, Beck, Kenneth W, Sharp
openaire +2 more sources
This article reviews the diagnosis and treatment of achalasia, a rare esophageal motility disorder characterized by absent peristalsis and failure of the lower esophageal sphincter (LES) to relax. Various treatment options including management with sublingual nitrates or calcium channel blockers, injection of the LES with botulism toxin, pneumatic ...
William C, Beck, Kenneth W, Sharp
openaire +2 more sources
Gastroenterology Clinics of North America, 2008
Achalasia is the best understood and most readily treatable esophageal motility disorder. It serves as a prototype for disorders of the enteric nervous system with degeneration of the myenteric neurons that innervate the lower esophageal sphincter (LES) and esophageal body.
Natasha, Walzer, Ikuo, Hirano
openaire +2 more sources
Achalasia is the best understood and most readily treatable esophageal motility disorder. It serves as a prototype for disorders of the enteric nervous system with degeneration of the myenteric neurons that innervate the lower esophageal sphincter (LES) and esophageal body.
Natasha, Walzer, Ikuo, Hirano
openaire +2 more sources
Best Practice & Research Clinical Gastroenterology, 2007
Achalasia is a rare motor disorder of the oesophagus, characterised by the absence of peristalsis and impaired swallow-induced relaxation. These motor abnormalities result in stasis of ingested food in the oesophagus, leading to clinical symptoms, such as dysphagia, regurgitation of food, retrosternal pain and weight loss.
openaire +2 more sources
Achalasia is a rare motor disorder of the oesophagus, characterised by the absence of peristalsis and impaired swallow-induced relaxation. These motor abnormalities result in stasis of ingested food in the oesophagus, leading to clinical symptoms, such as dysphagia, regurgitation of food, retrosternal pain and weight loss.
openaire +2 more sources